Cytosorbents Corporation

NasdaqCM:CTSO Stock Report

Market Cap: US$48.3m

Cytosorbents Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:CTSO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Dec 23BuyUS$10,000Edward JonesIndividual7,519US$1.33
13 Dec 23BuyUS$50,000Michael BatorIndividual37,594US$1.33
13 Dec 23BuyUS$100,000Phillip ChanIndividual75,188US$1.33
13 Dec 23BuyUS$10,000Jiny KimIndividual7,519US$1.33
13 Dec 23BuyUS$50,000Kathleen BlochIndividual37,594US$1.33
13 Dec 23BuyUS$25,000Vincent CapponiIndividual18,797US$1.33
13 Dec 23BuyUS$30,001Efthymios DeliargyrisIndividual22,557US$1.33
13 Dec 23BuyUS$30,001Alan SobelIndividual22,557US$1.33
07 Aug 23BuyUS$9,580Michael BatorIndividual3,000US$3.23
25 May 23BuyUS$9,389Kathleen BlochIndividual3,300US$2.85
10 May 23BuyUS$31,058Kathleen BlochIndividual10,000US$3.17

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CTSO?
Owner TypeNumber of SharesOwnership Percentage
Private Companies6,1550.0113%
Hedge Funds3,254,2135.99%
Individual Insiders4,354,3098.02%
Institutions17,247,99431.8%
General Public29,430,88454.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.3%.


Top Shareholders

Top 25 shareholders own 43.85% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.66%
Granahan Investment Management, LLC
3,618,143US$3.2m133%0.11%
5.99%
Skylands Capital, LLC
3,254,213US$2.9m10.5%0.41%
5.62%
Avenir Corporation
3,051,402US$2.7m12.3%0.22%
5.18%
Mary Ley
2,813,315US$2.5m0%no data
3.59%
The Vanguard Group, Inc.
1,949,551US$1.7m0%no data
3.32%
Neuberger Berman Investment Advisers LLC
1,801,799US$1.6m19.9%no data
2.41%
Sargent Investment Group, LLC
1,308,747US$1.2m4.11%0.24%
2.15%
Jackson National Asset Management, LLC
1,169,051US$1.0m96.4%0.02%
1.36%
Phillip Chan
739,370US$658.0k13.6%no data
1.34%
BlackRock, Inc.
726,320US$646.3k-0.06%no data
1.12%
Medical Strategy GmbH, Asset Management Arm
606,984US$540.2k-9.61%0.03%
0.76%
CM Management, LLC
415,000US$369.3k-7.78%0.34%
0.67%
Geode Capital Management, LLC
364,920US$324.7k0%no data
0.52%
Vincent Capponi
281,134US$250.2k12.4%no data
0.46%
Kathleen Bloch
247,941US$220.6k11.5%no data
0.38%
Perinvest (UK) Ltd
205,000US$182.4k0%0.17%
0.36%
Jacob Asset Management of New York LLC
197,940US$176.1k0%0.2%
0.34%
Victory Capital Management Inc.
184,895US$164.5k-2.22%no data
0.32%
Renaissance Technologies LLC
175,320US$156.0k47.2%no data
0.32%
CIBC Private Wealth Advisors, Inc.
172,649US$153.6k40.8%no data
0.28%
State Street Global Advisors, Inc.
151,093US$134.5k0%no data
0.22%
Morgan Stanley, Investment Banking and Brokerage Investments
116,882US$104.0k-0.66%no data
0.16%
Neuberger Berman Europe Limited
88,364US$78.6k0%no data
0.16%
Osaic Wealth, Inc. , Asset Management Arm
85,040US$75.7k-46%no data
0.15%
Efthymios Deliargyris
81,099US$72.2k72.6%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.